- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cantabio Pharmaceuticals Inc (CTBO)
Cantabio Pharmaceuticals Inc stock price live, this page displays OTC CTBO stock exchange data. View the CTBO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cantabio Pharmaceuticals Inc real time stock price chart below.
What Is the Cantabio Pharmaceuticals Inc Stock Price Today?
The Cantabio Pharmaceuticals Inc stock price today is 1.0100.
What Is the Stock Symbol for Cantabio Pharmaceuticals Inc?
The stock symbol for Cantabio Pharmaceuticals Inc is "CTBO."
What Stock Exchange Does Cantabio Pharmaceuticals Inc Trade On?
Cantabio Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Cantabio Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cantabio Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTBO quote. (ISIN: US13808X2036) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Cantabio Pharmaceuticals Inc Stock Price Today?
The Cantabio Pharmaceuticals Inc stock price today is 1.0100.
What Is the Stock Symbol for Cantabio Pharmaceuticals Inc?
The stock symbol for Cantabio Pharmaceuticals Inc is "CTBO."
What Stock Exchange Does Cantabio Pharmaceuticals Inc Trade On?
Cantabio Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Cantabio Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cantabio Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTBO quote. (ISIN: US13808X2036) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
OTC Markets
Currency in USD
1.0100
0.0000(0.00%)
Closed·
Fair Value
An estimate of a Cantabio Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0100
1.0100
52 wk Range
1.0100
1.0100
Trading near 52-week High
1/3
Fair Value
An estimate of a Cantabio Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.01001.0100
52 wk Range
1.01001.0100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CTBO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cantabio Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Cantabio Pharmaceuticals, Inc. operates as a pre-clinical drug development company focused on developing therapeutics for neurodegenerative and metabolic diseases. The company develops drug candidates for conditions such as Parkinson’s, Alzheimer’s, and type 2 diabetes, with an emphasis on disease-modifying therapeutics that address biochemical stress factors including protein misfolding, aggregation, oxidative stress, and glyoxal stress. It conducts in-house research and development, collaborates with academic institutions and industrial partners for high throughput screening and structural biology characterization, and maintains a discovery pipeline aimed at advancing drug candidates to clinical trials. The company engages in partnerships and project funding for specific therapeutic projects, such as those targeting the DJ-1 protein, and its research includes targeting intrinsically disordered proteins and developing pharmacological chaperones. Cantabio Pharmaceuticals serves academic research groups, contract research organizations, industrial partners in the pharmaceutical and biotechnology sectors, and medical research institutes involved in neurodegenerative and metabolic disease research. The company was founded in 2009 and is based in Palo Alto, California.
Compare CTBO to Peers and Sector
Metrics to compare | CTBO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCTBOPeersSector | |
|---|---|---|---|---|
P/E Ratio | Unlock | NaN | NaN | Unlock |
PEG Ratio | Unlock | NaN | NaN | Unlock |
Price/Book | Unlock | NaN | NaN | Unlock |
Price / LTM Sales | Unlock | NaN | NaN | Unlock |
Upside (Analyst Target) | Unlock | NaN | NaN | Unlock |
Fair Value Upside | Unlock | NaN | NaN | Unlock |
Earnings
Latest Release
Jun 17, 2019
EPS / Forecast
19.63 / --
Revenue / Forecast
-- / --
FAQ
What Is the Cantabio Pharma (CTBO) Stock Price Today?
The Cantabio Pharma stock price today is 1.0100 USD.
What Stock Exchange Does Cantabio Pharma Trade On?
Cantabio Pharma is listed and trades on the OTC Markets.
What Is the Stock Symbol for Cantabio Pharma?
The stock symbol for Cantabio Pharma is "CTBO."
What Is the Cantabio Pharma Market Cap?
As of today, Cantabio Pharma market cap is 24.3500K USD.
What Is Cantabio Pharma's Earnings Per Share (TTM)?
The Cantabio Pharma EPS (TTM) is -130.8327.
From a Technical Analysis Perspective, Is CTBO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cantabio Pharma Stock Split?
Cantabio Pharma has split 2 times.
What is the current trading status of Cantabio Pharma (CTBO)?
As of Apr 25, 2026, Cantabio Pharma (CTBO) is trading at a price of 1.0100 USD, with a previous close of 1.0100 USD. The stock has fluctuated within a day range of 1.0100 USD to 1.0100 USD, while its 52-week range spans from 1.0100 USD to 1.0100 USD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.